Navafenterol

Synonyms: AZD-8871; LAS191351
Navafenterol (AZD-8871) 是一种吸入型、双效、选择性且持久的 M3-拮抗剂/β2-激动剂 (MABA),对人 M3 受体的 pIC50 为 9.5,对 β2-肾上腺素受体的 pEC50 为 9.5,具有支气管保护和抗唾液分泌作用以及良好的心血管特征和安全性,可用于慢性阻塞性肺疾病 (COPD) 的研究。
产品编号: MS-N29503 CAS No.: 1435519-06-4 分子式: C38H42N6O6S2 分子量: 742.91
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
50mg
询价
询价
100mg
询价
询价
250mg
询价
询价

产品描述

Navafenterol (AZD-8871) 是一种吸入型、双效、选择性且持久的 M3-拮抗剂/β2-激动剂 (MABA),对人 M3 受体的 pIC50 为 9.5,对 β2-肾上腺素受体的 pEC50 为 9.5,具有支气管保护和抗唾液分泌作用以及良好的心血管特征和安全性,可用于慢性阻塞性肺疾病 (COPD) 的研究。

生物实验数据

生物活性 Navafenterol (AZD-8871) is an inhaled, dual-acting, selective, and long-acting M3 antagonist/β2 agonist (MABA) with a pIC50 of 9.5 for the human M3 receptor and a pEC50 of 9.5 for the β2-adrenoceptor, exhibiting bronchoprotective and antisecretory effects along with a favorable cardiovascular profile and good safety, and can be used for research on chronic obstructive pulmonary disease (COPD).
IC50 & Target

mAChR3

 

体外研究
(In Vitro)

The pIC50 values of Navafenterol (AZD-8871) at the human M1, M2, M3, M4, and M5 receptor are 9.9, 9.9, 9.5, 10.4, and 8.8, respectively.
pEC50 values of Navafenterol at theβ1, β2, and β3 adrenoceptor are 9.0, 9.5, and 8.7, respectively. It is selective for the β2-adrenoceptor over the β1 and β3 subtypes (3- and 6-fold, respectively).
Navafenterol shows kinetic selectivity for the M3 (half-life: 4.97 hours) over the M2 receptor (half-life: 0.46 hour).
Navafenterol shows dual antimuscarinic and β2-adrenoceptor functional activity in isolated guinea pig tissue (pIC50 in electrically stimulated trachea: 8.6; pEC50 in spontaneous tone isolated trachea: 8.8, respectively), which are sustained over time.

体内研究
(In Vivo)

Navafenterol (AZD-8871) prevents acetylcholine-induced bronchoconstriction in both guinea pig and dog with minimal effects on salivation and heart rate at doses with bronchoprotective activity. Moreover, AZD8871 shows long-lasting effects in dog, with a bronchoprotective half-life longer than 24 hours. Navafenterol shows dose-proportional bronchoprotective effect, with a nonsignificantly different potency (ID40 of 0.40 μg/kg).

Animal Model: Male Dunkin Hartley guinea pigs (body weight 340-600 g) bearing bronchoconstriction model
Dosage: 10, 30, 100, and 300 μg/mL
Administration: Administered by aerosol
Result: Inhibited the bronchoconstriction in a concentration-response manner with the IC50 value of 2.1 µg/mL.
Exhibited the antisialagogue effect with a maximal inhibition of sialorrhea of 65%±11% at 300 µg/mL and an estimated IC50 of 138.4 µg/mL.
Animal Model: Male anesthetized Beagle dogs
Dosage: 0.3, 1, 3, or 10 µg/kg
Administration: Administered as nebulized liquid aerosols; the administration volume was 3 mL
Result: Showed significant effects over 24 hours at all the doses tested (0.3-10 µg/kg).
Showed long-lasting effects at 10 µg/kg, with a 79% ± 3.6% of bronchoprotection at 24 hours and a calculated half-life longer than 24 hours. 

化学信息

分子量 742.91
分子式 C38H42N6O6S2
CAS No. 1435519-06-4
别名 AZD-8871; LAS191351

储存&溶解度

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础